Sweeny Nicole Insider Trades

Insider Trading History

Track insider trading activity for Sweeny Nicole. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monopar Therapeutics
Monopar Therapeutics MNPR
Director
Holding Value $128k 1,284 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 1,284 shares
$87.68
$99.79
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Jun 11, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$6.83M 253,041 shares
$27.00
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.6M 59,291 shares
Last Trade
May 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$39.9k 1,489 shares
$26.78
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.08M 40,000 shares
Last Trade
May 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$134k 5,000 shares
$26.79
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.64M 60,780 shares
Last Trade
May 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$134k 5,000 shares
$26.79
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.51M 55,780 shares
Last Trade
May 22, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$49.8k 1,861 shares
$26.78
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.86M 68,750 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$167k 6,250 shares
$26.77
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.56M 57,641 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$167k 6,250 shares
$26.77
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.39M 51,391 shares
Last Trade
Apr 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$37.6k 1,862 shares
$20.22
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $2.53M 93,750 shares
Last Trade
Apr 16, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 6,250 shares
$19.56
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.44M 53,253 shares
Last Trade
Apr 16, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$122k 6,250 shares
$19.56
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.27M 47,003 shares
Last Trade
Feb 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$61.9k 3,975 shares
$15.57
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.38M 50,978 shares
Last Trade
Feb 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$79.2k 5,000 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.22M 45,000 shares
Last Trade
Feb 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$79.2k 5,000 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $2.03M 75,000 shares
Last Trade
Feb 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$98.9k 6,250 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.24M 45,978 shares
Last Trade
Feb 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$98.9k 6,250 shares
$15.83
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $2.7M 100,000 shares
Last Trade
Jan 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.46M 100,000 shares
$14.60
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.07M 39,728 shares
Last Trade
Nov 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.3k 3,813 shares
$13.45
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.35M 50,000 shares
Last Trade
Nov 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$65.5k 5,000 shares
$13.10
$27.00
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
Chief Commercial Officer
Holding Value $1.18M 43,541 shares
Last Trade
Nov 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$65.5k 5,000 shares
$13.10
$27.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up